Mutations, polymorphisms and haplotypes of NFKBIA have been reported in Hodgkin’s lymphoma, colorectal cancer, melanoma, hepatocellular carcinoma, breast cancer and multiple myeloma (25–37). This evidence concerns the gene NFKBIA and breast cancer.